The largest database of trusted experimental protocols

6 protocols using ldh based cytotoxicity detection kit

1

Cytotoxicity Assay of NTZ in Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were seeded into 96-well plates at a density of 2 × 104 cells per well and treated with serially diluted NTZ for 48 h in quadruplicate. NTZ cytotoxicity and growth inhibition was assessed with a LDH-Based cytotoxicity detection kit (Roche) using the modified protocol (Smith et al., 2011 ).
+ Open protocol
+ Expand
2

Cytotoxicity Evaluation of Cell Cultures

Check if the same lab product or an alternative is used in the 5 most similar protocols
In order to evaluate vitality of cells in our different culture setups, lactate dehydrogenase (LDH) concentration in supernatants of BMSC, mixed cultures and chondrocytes was determined in monocultures and co- or tricultures with OAB kept in chondrogenic medium. Content of LDH was analyzed at days 7, 14, 21 and 28 with an LDH-based cytotoxicity detection kit (Roche Diagnostics, Penzberg, Germany) and compared to respective assay controls (high control = all cells in fibrin gels were lysed; low control = spontaneous cell death of an equivalent cell amount in monolayer) according to the manufacturer’s instructions. LDH concentration released from dead cells into supernatant was determined on a photometrical basis at absorption of 490 nm (Tecan GENios with Magellan 6.5; Tecan, Crailsheim, Germany). Due to high interexperimental variability - presumably caused by personal living conditions and physical activity, medical treatment or general health status of tissue donors - we have calculated the raw data as percentage of control per individual experiment. Repetition was in triplicate at least three times with cells and explants from different donors.
+ Open protocol
+ Expand
3

Evaluating DMF's Effects on Cell Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
The effect of DMF on cell proliferation was measured by quantifying BrdU via a cell proliferation immunoassay from Roche Diagnostics (Grenzach, Germany). Forty-eight hours after seeding (1 × 104 cells per 96-well), cells were incubated with BrdU and DMF at the indicated concentrations for 24 h. The cytotoxic potential of DMF was determined using an LDH-based cytotoxicity detection kit from Roche. Forty-eight hours after seeding (1 × 104 cells per 96-well), the cells were incubated under serum-reduced conditions (1% FCS) with DMF for 24 h at the indicated concentrations.
+ Open protocol
+ Expand
4

Evaluating DD-LEEI-RSV in Human Lung Tissue

Check if the same lab product or an alternative is used in the 5 most similar protocols
The use of lung tissue was approved by the Ethics Committee of the Hannover Medical School (MHH, Hannover, Germany) and was in compliance with “The Code of Ethics of the World Medical Association” (renewed on 2015/04/22, number 2701-2015). All patients gave written informed consent for the use of their lung tissue for research. Human precision-cut lung slices (PCLS) were prepared as described previously (31 (link)). PCLS containing airways were treated with different concentrations of DD-LEEI-RSV and cultured in DMEM/F12 with penicillin and streptomycin (10,000 U/mL, Gibco) at 37°C with 5% CO2 for up to 72 h.
Tissue viability was assessed using the lactate dehydrogenase (LDH)-based Cytotoxicity Detection Kit (Roche, Switzerland) and the metabolic activity-based Cell Proliferation Reagent WST-1 (Roche). Adverse immunomodulatory effects were assessed by IL-6 and TNF-α in the supernatants by using ELISA (RnD, DuoSet, USA). All kits and reagents were applied at the manufacturer’s recommendations.
+ Open protocol
+ Expand
5

Cell Viability Evaluation in 2D and 3D

Check if the same lab product or an alternative is used in the 5 most similar protocols
2D cell viability following 48–72 h drug treatment was evaluated using CellTiter-Glo reagent (Promega) according to manufacturer’s instructions. Assays were performed in triplicate and experiments were repeated three times in all five cell lines. Spheroids were successfully developed in three of the cell lines, UOK109, UOK120, and UOK124, using a previously described methodology [24 (link)] to evaluate 3D cell viability. Spheroids were incubated with drug for five days, before assessing viability by CellTiter-Glo 3D Cell Viability Assay (Promega). Calculation of drug synergy was performed with Compusyn [25 (link)], according to software instructions, including at least 6 concentration points for each drug alone and in combination. Cell cytotoxicity in vitro was measured with the lactate dehydrogenase (LDH)-based Cytotoxicity Detection Kit (Roche) as previously described [26 (link)].
+ Open protocol
+ Expand
6

Evaluating Cytotoxicity and Oxidative Stress

Check if the same lab product or an alternative is used in the 5 most similar protocols
Trypsin, penicillin, streptomycin, neutral red solution, 2′,7′-dichlorodihydrofluorescein diacetate (H2DCFDA), phosphate-buffered saline (PBS) without Ca2+ and Mg2+, hydrocortisone, Hoechst 33342, calcein AM, sodium pyruvate, sodium bicarbonate, fetal bovine serum (FBS), N-acetyl-L-cysteine (NAC), staurosporine, Ac-DEVD-CHO (caspase-3 inhibitor), hydrogen peroxide (H2O2) and dimethyl sulfoxide (DMSO) were purchased from Sigma–Aldrich (St. Louis, MO, USA). The DMEM/F12 (1:1) medium was purchased from ATCC (Manassas, VA, USA). Caspase-3 substrate (Ac-DEVD-pNA) was purchased from Calbiochem (Merck Corporation, Darmstadt, Germany). The LDH-based cytotoxicity detection kit was purchased from Roche Applied Science (Mannheim, Germany). H2DCFDA, Hoechst 33342, calcein AM and staurosporine stock solutions were prepared by dissolving the compounds in DMSO. Plant extracts were dissolved in ethanol. The final concentration of ethanol in the culture medium was always 0.1%.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!